Llorca J - Search Results

1

No evidence for association of the monocyte chemoattractant protein-1 (-2518) gene polymorphism and Alzheimer's disease.

Combarros O, Infante J, Llorca J, Berciano J. Combarros O, et al. Among authors: llorca j. Neurosci Lett. 2004 Apr 22;360(1-2):25-8. doi: 10.1016/j.neulet.2004.01.035. Neurosci Lett. 2004. PMID: 15082170

2

Polymorphism at codon 129 of the prion protein gene is not associated with sporadic AD.

Combarros O, Sánchez-Guerra M, Llorca J, Alvarez-Arcaya A, Berciano J, Peña N, Fernández-Viadero C. Combarros O, et al. Among authors: llorca j. Neurology. 2000 Aug 22;55(4):593-5. doi: 10.1212/wnl.55.4.593. Neurology. 2000. PMID: 10953203

3

The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women.

Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Viadero C, Peña N. Alvarez-Arcaya A, et al. Among authors: llorca j. Acta Neurol Scand. 2000 Dec;102(6):350-3. doi: 10.1034/j.1600-0404.2000.102006350.x. Acta Neurol Scand. 2000. PMID: 11125748

4

The Glu298Asp polymorphism in the NOS3 gene is not associated with sporadic Alzheimer's disease.

Sánchez-Guerra M, Combarros O, Alvarez-Arcaya A, Mateo I, Berciano J, González-García J, Llorca J. Sánchez-Guerra M, et al. Among authors: llorca j. J Neurol Neurosurg Psychiatry. 2001 Apr;70(4):566-7. doi: 10.1136/jnnp.70.4.566. J Neurol Neurosurg Psychiatry. 2001. PMID: 11300106 Free PMC article. No abstract available.

5

The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.

Alvarez-Arcaya A, Combarros O, Llorca J, Sánchez-Guerra M, Berciano J, Fernández-Luna JL. Alvarez-Arcaya A, et al. Among authors: llorca j. Neurosci Lett. 2001 May 25;304(3):204-8. doi: 10.1016/s0304-3940(01)01790-6. Neurosci Lett. 2001. PMID: 11343837

6

Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease.

Sánchez-Guerra M, Combarros O, Infante J, Llorca J, Berciano J, Fontalba A, Fernández-Luna JL, Peña N, Fernández-Viadero C. Sánchez-Guerra M, et al. Among authors: llorca j. Neurosci Lett. 2001 Dec 4;316(1):17-20. doi: 10.1016/s0304-3940(01)02342-4. Neurosci Lett. 2001. PMID: 11720768

7

Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample.

Mateo I, Sánchez-Guerra M, Combarros O, Llorca J, Infante J, González-García J, del Molino JP, Berciano J. Mateo I, et al. Among authors: llorca j. Am J Med Genet. 2002 Jan 8;114(1):31-3. doi: 10.1002/ajmg.1623. Am J Med Genet. 2002. PMID: 11840502

8

The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis.

Combarros O, Infante J, Llorca J, Peña N, Fernández-Viadero C, Berciano J. Combarros O, et al. Among authors: llorca j. Neurosci Lett. 2002 Jun 21;326(1):33-6. doi: 10.1016/s0304-3940(02)00303-8. Neurosci Lett. 2002. PMID: 12052532

9

No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease.

Infante J, Llorca J, Berciano J, Combarros O. Infante J, et al. Among authors: llorca j. Neurosci Lett. 2002 Aug 2;328(1):71-3. doi: 10.1016/s0304-3940(02)00453-6. Neurosci Lett. 2002. PMID: 12123862

10

Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.

Combarros O, Sánchez-Guerra M, Infante J, Llorca J, Berciano J. Combarros O, et al. Among authors: llorca j. J Neurol. 2002 Sep;249(9):1242-5. doi: 10.1007/s00415-002-0819-9. J Neurol. 2002. PMID: 12242547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters